TY - JOUR
T1 - The impacts of deep surgical site infections on readmissions, length of stay, and costs
T2 - A matched case–control study conducted in an academic hospital in the netherlands
AU - Purba, Abdul Khairul Rizki
AU - Luz, Christian F.
AU - Wulandari, Riyanti R.
AU - van der Gun, Ieneke
AU - Dik, Jan Willem
AU - Friedrich, Alex W.
AU - Postma, Maarten J.
N1 - Publisher Copyright:
© 2020 Purba et al.
PY - 2020
Y1 - 2020
N2 - Objective: This study aimed to evaluate the impacts of deep surgical site infections (dSSIs) regarding hospital readmissions, prolonged length of stay (LoS), and estimated costs. Patients and Methods: We designed and applied a matched case–control observational study using the electronic health records at the University Medical Center Groningen in the Netherlands. We compared patients with dSSI and non-SSI, matched on the basis of having similar procedures. A prevailing topology of surgeries categorized as clean, clean-contami-nated, contaminated, and dirty was applied. Results: Out of a total of 12,285 patients, 393 dSSI were identified as cases, and 2864 patients without SSIs were selected as controls. A total of 343 dSSI patients (87%) and 2307 (81%) controls required hospital readmissions. The median LoS was 7 days (P25-P75: 2.5–14.5) for dSSI patients and 5 days (P25-P75: 1–9) for controls (p-value: <0.001). The estimated mean cost per hospital admission was €9,016 (SE±343) for dSSI patients and €5,409 (SE±120) for controls (p<0.001). Independent variables associated with dSSI were patient’s age ≥65 years (OR: 1.334; 95% CI: 1.036–1.720), the use of prophylactic antibiotics (OR: 0.424; 95% CI: 0.344–0.537), and neoplasms (OR: 2.050; 95% CI: 1.473–2.854). Conclusion: dSSI is associated with increased costs, prolonged LoS, and increased read-mission rates. Elevated risks were seen for elderly patients and those with neoplasms. Additionally, a protective effect of prophylactic antibiotics was found.
AB - Objective: This study aimed to evaluate the impacts of deep surgical site infections (dSSIs) regarding hospital readmissions, prolonged length of stay (LoS), and estimated costs. Patients and Methods: We designed and applied a matched case–control observational study using the electronic health records at the University Medical Center Groningen in the Netherlands. We compared patients with dSSI and non-SSI, matched on the basis of having similar procedures. A prevailing topology of surgeries categorized as clean, clean-contami-nated, contaminated, and dirty was applied. Results: Out of a total of 12,285 patients, 393 dSSI were identified as cases, and 2864 patients without SSIs were selected as controls. A total of 343 dSSI patients (87%) and 2307 (81%) controls required hospital readmissions. The median LoS was 7 days (P25-P75: 2.5–14.5) for dSSI patients and 5 days (P25-P75: 1–9) for controls (p-value: <0.001). The estimated mean cost per hospital admission was €9,016 (SE±343) for dSSI patients and €5,409 (SE±120) for controls (p<0.001). Independent variables associated with dSSI were patient’s age ≥65 years (OR: 1.334; 95% CI: 1.036–1.720), the use of prophylactic antibiotics (OR: 0.424; 95% CI: 0.344–0.537), and neoplasms (OR: 2.050; 95% CI: 1.473–2.854). Conclusion: dSSI is associated with increased costs, prolonged LoS, and increased read-mission rates. Elevated risks were seen for elderly patients and those with neoplasms. Additionally, a protective effect of prophylactic antibiotics was found.
KW - Cost
KW - Economic evaluation
KW - Patient admission
KW - Prophylactic antibiotic
KW - Surgical wound infection
UR - http://www.scopus.com/inward/record.url?scp=85092032628&partnerID=8YFLogxK
U2 - 10.2147/IDR.S264068
DO - 10.2147/IDR.S264068
M3 - Article
AN - SCOPUS:85092032628
SN - 1178-6973
VL - 13
SP - 3365
EP - 3374
JO - Infection and Drug Resistance
JF - Infection and Drug Resistance
ER -